The explosive growth of oil and gas production in the U.S. is enough to pique the interest of any investor. While the price of natural gas has remained stubbornly low, crimping profits, the price of oil, on the other hand, has remained rather elevated. That's producing profits for oil companies, making those stocks a temping investment opportunity. While there are many names that could do well, below are the three oil stocks that I think will treat the long-term investor very well.
ConocoPhillips (NYSE: COP )
With its large global asset base, ConocoPhillips is the largest of the U.S. independent E&P companies. Its global scale provides investors with a certain safety, as it's not as exposed to regional commodity price disruptions as the other oil stocks to follow. That provides more certainty that Conoco can fulfil its goal of growing its production and margins by 3%-5% annually through 2017.
Hot Valued Stocks To Invest In Right Now: Dreyfus Strategic Municipal Bond Fund Inc (DSM)
Dreyfus Strategic Municipal Bond Fund, Inc. (the fund) is a diversified closed-end management investment company. The fund�� investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. The Dreyfus Corporation serves as the fund�� investment adviser.
The fund invests at least 80% of its assets in municipal bonds. The fund also issues auction rate preferred stock and invests the proceeds in a manner consistent with its investment objective.
Advisors' Opinion:- [By Tom Stoukas]
Royal DSM NV (DSM) slid 5.4 percent to 55.13 euros. The company that spent $3.2 billion on nutrition-ingredient acquisitions said profit this year may fall short of an initial target because of stagnant markets in Europe and lower chemical prices.
- [By Trista Kelley]
Cenkos Securities Plc (CNKS) is running the spinoff and the share sale. Royal DSM NV (DSM), the world�� largest maker of vitamins, holds about 9 percent of SiS, while U.K. venture-capital trust Downing LLP owns 16.7 percent, Moon said. Provexis stockholders received one share of Science in Sport for every 100 shares of Provexis.
- [By Sherine El Madany]
Dubai�� DFM General Index (DSM) posted the biggest drop in the Middle East, losing 2.3 percent, the most since June 10, to 2,345.47 at the 2 p.m. close in the emirate. Emaar Properties PJSC (EMAAR), developer of the world�� tallest tower in Dubai, registered its biggest decrease since April. The ADX General Index (MSM30) fell 0.9 percent, while the Bloomberg GCC200 Index (BGCC200) was down 0.2 percent.
Top Companies To Own For 2014: Pernix Therapeutics Holdings Inc (PTX)
Pernix Therapeutics Holdings, Inc. (Pernix), incorporated in November 8, 1996, is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products for pediatric and adult indications in a range of therapeutic areas. It manages a portfolio of branded and generic products and theobromine, a non-codeine, cough suppressant product candidate in development. The Company�� branded products for the pediatrics market include CEDAX, an antibiotic for middle ear infections, NATROBA, a topical treatment for head lice marketed under an exclusive co-promotion agreement with ParaPRO, LLC and a family of prescription treatments for cough and cold (BROVEX, ALDEX and PEDIATEX). It also markets REZYST IM, which is a probiotic blend to promote dietary management. Pernix markets generic products through its wholly owned subsidiary, Macoven Pharmaceuticals, LLC. In January 2013, the Company acquired Cypress Pharmaceuticals, Inc. and Hawthorn Pharmaceuticals, Inc. In March 2013, the Company acquired Somaxon Pharmaceuticals Inc. In September 2013, Pernix Therapeutics Holdings, Inc. completed the sale of certain non-core assets to Breckenridge Pharmaceutical, Inc.
The Company�� customers consist of drug wholesalers, retail drug stores, mass merchandisers and grocery store pharmacies in the United States. It primarily sells products directly to drug wholesalers, which in turn distribute the products to retail drug stores, mass merchandisers and grocery store pharmacies.
ALDEX Line
ALDEX is a line of antihistamines, decongestants and cough suppressants that are indicated for the temporary relief of respiratory allergies, allergic rhinitis and symptoms of the common cold. The Company�� ALDEX product line is marketed in a range of formulations and combinations using different drug-delivery methodologies to target specific segments of the antihistamine, decongestant and cough suppressant markets. Two used decongestants ar! e phenylephrine and pseudoephedrine.
BROVEX Line
The BROVEX line is a line of antihistamine combinations with the active pharmaceutical ingredient (API) brompheniramine maleate, part of the first generation class of antihistamines called alkylamines that are indicated for the temporary relief of sneezing, itchy, watery eyes, itchy nose or throat, and runny nose due to hay fever or other respiratory allergies. Its BROVEX product line is marketed in a range of formulations and combinations to target specific segments of the antihistamine market. The Company completed the conversion of the BROVEX product family to over-the-counter (OTC) monograph from DESI drugs, in April 2011.
CEDAX Line
CEDAX is a third generation oral cephalosporin indicated for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza or streptococcus pyogenes. The Company sells a range of dosages utilizing both capsule and oral suspension drug delivery methodologies. It also owns a trademark on the name CEDAX in the United States.
NATROBA Line
NATROBA Topical Suspension is a prescription medicine used to treat head lice (pediculosis capitis) in adults and children four years of age and older. NATROBA contains the active ingredient spinosad, which is derived from a naturally occurring soil bacterium.
PEDIATEX Line
As of December 31, 2011, the only product that the Company marketed and sold in its PEDIATEX line is PEDIATEX TD. PEDIATEX TD is an antihistamine/nasal decongestant combination liquid for oral administration. Each 1 milliliter dose contains the API Tripolidine HC1 and Pseudoephedrine HC1. Tripolidine HC1 is a first generation antihistamine in the alkylamine class. Pseudoephedrine, a decongestant, is a sympathomimetic, which acts on alpha-adrenergic receptors in the mucosa of the respiratory tract, producing vasoconstriction and having minimal eff! ect on be! ta-receptors. It therefore functions as an oral nasal decongestant with minimal central nervous system stimulation.
REZYST Line
REZYST IM is a probiotic blend that promotes the dietary management of patients with the distinctive nutritional requirements associated with the gastro-intestinal flora. It is formulated to improve the digestive health of patients by replacing the active cultures altered by diet, stress, and antibiotics.
Product Candidates in Development
Product candidates in development include Theobromine. Theobromine is an alkaloid naturally present in dark chocolate which is an existing human metabolite of caffeine. The Company is working on several other product candidates, which includes a prescription product for the pediatrics market. In March 2012, the Company entered into a product development agreement with a private company for this product.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Wednesday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Horizon Pharma (NASDAQ: HZNP) and Pernix Therapeutics Holdings (NASDAQ: PTX). In trading on Wednesday, telecommunications services shares were relative laggards, down on the day by about 0.39 percent. Top decliners in the sector included Shenandoah Telecommunications Co (NASDAQ: SHEN), off 3.3 percent, and CalAmp (NASDAQ: CAMP), down around 2.4 percent.
Top Companies To Own For 2014: Emeritus Corporation (ESC)
Emeritus Corporation operates senior living communities in the United States. The company�s communities offer Alzheimer�s and dementia care, independent living, assisted living, specialized memory care, and skilled nursing care services. It also provides management services to independent and related-party owners of assisted living communities. As of November 15, 2012, the company operated approximately 470 senior living communities in 44 states with a resident capacity for approximately 50,000 residents. Emeritus Corporation was founded in 1993 and is headquartered in Seattle, Washington.
Advisors' Opinion:- [By Sean Williams]
One company with seemingly limitless upside potential today was senior housing operator Emeritus (NYSE: ESC ) , which gained 35.2% after agreeing to be purchased by Brookdale Senior Living (NYSE: BKD ) for $1.4 billion, excluding debt. Under the terms of the deal, Emeritus shareholders will receive 0.95 shares of Brookdale, and would effectively own 23% of the outstanding shares of the company once the merger is complete. Brookdale anticipates the deal being EPS neutral in 2014, and forecasts it adding $0.40 in EPS by the third year. The move certainly makes sense on paper, as cost synergies will help these two senior housing companies fight back against the expectation of declining Medicare reimbursement rates. However, over the long run, the Medicare reimbursement picture is still very cloudy, making Brookdale a riskier buy at the moment following today's announcement.
- [By John Kell]
Brookdale Senior Living Inc.(BKD) has agreed to merge with Emeritus Corp.(ESC) in a deal that values the operator of long-term, assisted-living facilities at about $1.4 billion, as the companies look to form a national senior-living-solutions company. Emeritus surged 34% to $28.75 premarket.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Emeritus (NYSE: ESC ) , whose recent revenue and earnings are plotted below.
Top Companies To Own For 2014: Generac Holdlings Inc. (GNRC)
Generac Holdings Inc. designs, manufactures, and markets a range of generators and other engine powered products for the residential, light commercial, industrial, and construction markets in the United States and Canada. It offers generators and other products fueled by natural gas, liquid propane, gasoline, diesel, and Bi-Fuel under the Generac and Magnum brands. The company�s product line includes residential power products, commercial and industrial power products, and other products. Its residential power products comprise automatic residential standby generators that range in output from 6kW to 60kW; air-cooled residential standby generators, which range in outputs from 6kW to 20kW; and liquid-cooled generators that range in outputs from 20kW to 60kW. The residential power product line also includes portable generators consisting of GP series ranging from 1,850W to 17,500W for homeowners; the XG series ranging from 4,000W to 10,000W for the premium homeowner market; the XP series ranging from 4,000W to 8,000W for the professional contractor market; and the iX series ranging from 800W to 2,000W for the recreational market. The company�s industrial and commercial power products comprise light-commercial standby generators ranging from 22kW to 150kW for grocery stores, convenience stores, restaurants, gas stations, pharmacies, retail banks, and healthcare facilities; single-engine industrial generators, which range in output from 10kW to 600kW; and generator systems ranging from 20kW air-cooled generators to 3mW modular power system for the telecommunications market, as well as aftermarket service parts and RV generators. The company sells its generators through independent residential and industrial dealers, wholesalers, national accounts, private label arrangements, retailers, catalogs, e-commerce merchants, equipment rental companies and dealers, and construction companies. Generac Holdings Inc. was founded in 1959 and is headquartere d in Waukesha, Wisconsin.
Advisors' Opinion:- [By Rich Duprey]
Generator maker Generac (NYSE: GNRC ) announced this morning it had completed the refinancing of its senior secured�term loan credit facility and, as it previously promised, will use part of the proceeds to pay investors a special dividend of $5.00 per share,�payable on June 21�to stockholders of record on June 12.�
No comments:
Post a Comment